| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | BBNX Beta Bionics, Inc. | Saint Sean60 | President &CEO | Sell | 3,359 | $18.86 | $63,361.49 | -3.2% | +55.3% | - | |
| Sep 2, 2025 | LUNG Pulmonx Corp | Rose Geoffrey Beran81 | Chief Commercial Officer | Sell | 6,543 | $1.60 | $10,468.80 | -0.4% | +1.7% | - | |
| Sep 2, 2025 | LFWD Lifeward Ltd. | Lynch Jeannine80 | VP Of Market Access &Strategy | Sell | 1,591 | $0.64 | $1,018.24 | -3.3% | -10.9% | - | |
| Sep 2, 2025 | INCY Incyte Corp | Denton Sheila A. | EVP &General Counsel | Sell | 598 | $84.97 | $50,812.06 | -1.8% | +18.7% | - | |
| Sep 2, 2025 | BBNX Beta Bionics, Inc. | Mensinger Mike73 | Chief Product Officer | Sell | 1,089 | $18.86 | $20,542.02 | -1.2% | +55.3% | - | |
| Aug 29, 2025 | IRIX Iridex Corp | Dizon Romeo R58 | Chief Financial Officer | Buy | 625 | $1.37 | $856.25 | +1.2% | -28.4% | - | |
| Aug 29, 2025 | INSP Inspire Medical Systems, Inc. | Buchholz Richard70 | Chief Financial Officer | Sell | 11,000 | $93.39 | $1,027,290.00 | -19.7% | +32.8% | - | |
| Aug 29, 2025 | ISRG Intuitive Surgical Inc | Guthart Gary S | Executive Chair Of The Board O | Sell | 29,360 | $472.49 | $13,872,227.13 | -59.7% | +21.2% | - | |
| Aug 29, 2025 | SERA Sera Prognostics, Inc. | Kearney Paul81 | Chief Data Officer | Sell | 10,542 | $3.49 | $36,791.58 | -5.6% | +3.1% | - | |
| Aug 28, 2025 | IRIX Iridex Corp | Dizon Romeo R58 | Chief Financial Officer | Buy | 1,005 | $1.35 | $1,355.80 | +0.5% | -29.1% | - | |
| Aug 28, 2025 | NXGL Nexgel, Inc. | Levy Adam R.77 | Chief Executive Officer | Sell | 4,000 | $2.47 | $9,896.40 | -1.1% | -25.7% | - | |
| Aug 28, 2025 | RCEL Avita Medical, Inc. | McNamara Robert | Director | Buy | 10,000 | $4.50 | $45,000.00 | +13.0% | -10.7% | - | |
| Aug 27, 2025 | AORT Artivion, Inc. | Stanton Marshall S. | SVP, Clinical &MD Affair | Sell | 18,200 | $44.02 | $801,218.60 | -22.1% | +7.1% | - | |
| Aug 27, 2025 | ICUI Icu Medical Inc/de | Greenberg David C.66 | Director | Buy | 1,200 | $126.42 | $151,698.29 | +8.5% | +20.0% | - | |
| Aug 27, 2025 | CBLL Ceribell, Inc. | Foehr David | Senior VP, Finance And Pao | Sell | 866 | $11.71 | $10,140.86 | -4.1% | +49.6% | - | |
| Aug 27, 2025 | STSS Sharps Technology Inc. | Ruemler Timothy James | Director | Sell | 20,000 | $16.74 | $334,786.00 | -15.3% | -78.7% | - | |
| Aug 27, 2025 | IRIX Iridex Corp | Dizon Romeo R58 | Chief Financial Officer | Buy | 1,000 | $1.28 | $1,282.75 | +0.7% | -29.0% | - | |
| Aug 26, 2025 | BLFS Biolife Solutions Inc | Aebersold Sarah61 | Chief Human Resources Officer | Sell | 219 | $25.44 | $5,571.36 | -0.3% | +2.7% | - | |
| Aug 26, 2025 | BLFS Biolife Solutions Inc | Werner Sean64 | Chief Technology Officer | Sell | 111 | $25.44 | $2,823.84 | -0.4% | +2.7% | - | |
| Aug 26, 2025 | RCEL Avita Medical, Inc. | O'Toole David D47 | CFO | Buy | 2,000 | $4.52 | $9,040.00 | +6.7% | -17.8% | - | |
| Aug 26, 2025 | IRIX Iridex Corp | Dizon Romeo R58 | Chief Financial Officer | Buy | 1,000 | $1.26 | $1,257.50 | +1.0% | -27.9% | - | |
| Aug 26, 2025 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 590 | $25.44 | $15,009.60 | -0.3% | +2.7% | - | |
| Aug 26, 2025 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 354 | $25.44 | $9,005.76 | -0.3% | +2.7% | - | |
| Aug 26, 2025 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 531 | $25.44 | $13,508.64 | -0.2% | +2.7% | - | |
| Aug 26, 2025 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality And Operations | Sell | 413 | $25.44 | $10,506.72 | -0.2% | +2.7% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.